Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 12495791 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Expansion of TILs utilizing AKT pathways inhibitors2025
Processes for generating TIL products enriched for tumor antigen-specific t-cell2024
Processes for generating TIL products enriched for tumor antigen-specific t-cell2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Processes for generating TIL products enriched for tumor antigen-specific T-cell2023
Processes for generating TIL products enriched for tumor antigen-specific T-cell2023
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2022